China Medical & HealthCare Group Limited provided earnings guidance for the six months ended December 31, 2018. For the six months, the company expected to record a profit attributable to shareholders of the Company as compared with a loss for the corresponding six months period in 2017 recorded by the Group mainly due to (i) a gain in fair value change of investments held for trading compared with a loss recorded in 2017; (ii) the decrease in finance costs; and (iii) an overall tax credit, which were partially off-set by the absence of imputed interest income from promissory notes receivables in the period under review.